Taipei: Taiwan’s Food and Drug Administration (FDA) has ordered a recall of 410,000 cans of the popular Japanese indigestion medicine Ohta’s Isan after discrepancies were found between its Chinese and Japanese ingredient labels.

According to Focus Taiwan, thirty-seven batches across three product sizes are being recalled by Sept. 18, after a consumer reported that the Japanese labeling of active ingredients on the outer packaging did not match the approved Chinese version, the FDA said Tuesday.

The affected batches include 16 batches of the 75 gram product, 16 batches of the 140 g product, and five batches of the 210 g product, according to the agency.

FDA official Yang Po-wen said the product, imported by Yuo Shiang Industrial Co., is an over-the-counter drug approved with Chinese labeling. Because the Japanese labeling was inconsistent, the FDA ordered a recall.

The distributor must complete the recall and submit a corrective report by Sept. 18, or face fines of NT$200,000 (US$6,550) to NT$5 million under the Pharmaceutical Affairs Act, Yang said.

In addition, the labeling inconsistency may constitute a violation of Article 46 of the act, punishable by fines of NT$30,000 to NT$2 million, he said.